Study guide

Hematology Quality Flags, Specimen Issues, and Smear Review Decisions

ASCP MLT Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 ASCP MLT Exam Overview and Laboratory Operations

Current Exam Facts and CAT Scoring Eligibility Routes and MLT Study Strategy Laboratory Safety, Quality, and Compliance Lab Math, Instrumentation Troubleshooting, and Result Verification

2 Chemistry, Urinalysis, and Body Fluid Interpretation

Chemistry Calculations, Acid-Base, and Electrolytes Renal, Liver, Endocrine, Enzyme, TDM, and Toxicology Patterns Chemistry QC, Interferences, Specimen Handling, and Result Correlation Urinalysis Microscopy and Body Fluid Decision Patterns

3 Hematology and Hemostasis

CBC, RBC Indices, Reticulocytes, and Anemia Patterns Leukocyte Morphology, Differentials, and Disease Clues Platelet Findings, Coagulation Pathways, PT/aPTT, and Hemostasis Testing Hematology Quality Flags, Specimen Issues, and Smear Review Decisions

4 Blood Banking and Transfusion Practice

ABO/Rh Typing: Forward, Reverse, and Discrepancies Antibody Screen, Identification, DAT, Elution, and Enhancement Methods Compatibility Testing, Crossmatch, Components, and Storage Transfusion Reactions, HDFN, Donor/Product Decisions, and Safety Workflow

5 Microbiology Workups and Susceptibility Reasoning

Specimen Quality, Safety, and Culture Setup Gram Stain, Media, and Biochemical Identification Mycology, Mycobacteriology, Virology, and Parasitology Essentials Antimicrobial Susceptibility, QC, and Postanalytic Reporting

6 Immunology, Integrated Cases, and Final Review

Immunology Principles, Autoimmune Testing, Infectious Serology, and Molecular/Serologic Methods Transplant, Complement, Immunoglobulins, and Result Interpretation Integrated Case Reasoning Across Departments Final Seven-Day Review, CAT Pacing, and Remediation

Hematology Quality Flags, Specimen Issues, and Smear Review Decisions

Key Takeaways Explain This Topic AI

A flagged CBC should be resolved by specimen check, analyzer review, smear correlation, and SOP-based action rather than by automatic release.

Clotted EDTA specimens can falsely lower platelet and WBC counts and are generally unacceptable for CBC reporting.

Cold agglutinins, lipemia, icterus, platelet clumps, and nucleated RBCs can create recognizable CBC inconsistencies.

Smear review decisions depend on flags, critical values, delta changes, abnormal scatterplots or histograms, and mismatch between numbers and morphology.

The MLT quality role is to protect result integrity: verify, correct, comment, recollect, or escalate when the data do not fit.

Last updated: May 2026

From Analyzer Flag to Reportable Result

The ASCP MLT guideline includes spurious results, manual and automated cell counts, differentials, morphology evaluation, indices, and laboratory quality protocols within hematology preparation. This is where bench judgment matters. A modern analyzer is powerful, but it cannot replace specimen inspection, smear correlation, and SOP-based decision making.

Common CBC specimen problems

Problem How it may appear Practical MLT action

Clotted EDTA sample Falsely low platelets or WBCs, fibrin strands, analyzer aspiration issues Reject or recollect according to SOP; do not report affected counts

Platelet clumps Low platelet count, platelet clump flag, clumps on smear edge Review smear; request recollection or alternate tube if procedure allows

Cold agglutinins Low RBC, high MCV, high MCHC, RBC agglutination on smear Warm and rerun if allowed; correlate Hgb/Hct and comment per SOP

Lipemia or icterus Interference with photometric hemoglobin, high MCHC mismatch Follow interference procedure; do not average discrepant results

nRBCs present WBC falsely increased on some analyzers Correct WBC when required and report nRBCs per policy

Hemolysis from draw trauma Plasma/serum discoloration; may affect chemistry more than CBC Evaluate whether CBC or coag result is affected; recollect if needed

EDTA is the standard anticoagulant for CBCs and blood smears. Smears should be prepared promptly when morphology matters because aging EDTA blood can create artifacts: neutrophil swelling, vacuolization, platelet swelling, crenated RBCs, and poor staining. For coagulation, the light-blue citrate tube must be filled properly and checked for clots before plasma testing.

Analyzer flags that deserve attention

Analyzer flags are instrument-specific, but common categories include blasts or abnormal WBC scatter, immature granulocytes, left shift, atypical lymphocytes, NRBCs, platelet clumps, giant platelets, RBC fragments, RBC agglutination, dimorphic RBC population, and high MCHC. A flag does not automatically prove a diagnosis. It tells the MLT that the automated result needs correlation.

Histograms and scatterplots help explain flags. A poor WBC separation may mean immature cells, blasts, fragile lymphocytes, or interference. A platelet histogram that does not return to baseline can suggest giant platelets, microcytic RBC interference, or fragments. RBC histograms may show dimorphic populations after transfusion or treatment, and RDW may rise accordingly.

Smear review workflow

Use a consistent sequence before release:

Verify patient and specimen identity, tube type, volume, clot status, and age.

Check QC and analyzer status; do not troubleshoot a patient result while QC is unresolved.

Compare current results with prior values for delta changes and clinical plausibility.

Review analyzer flags, histograms, and scatterplots.

Make and stain a good smear when criteria are met.

Examine the feather edge for clumps and large abnormal cells, then perform morphology in the monolayer.

Decide whether to release, correct, comment, recollect, repeat, perform manual differential, or escalate.

A good smear has a smooth feather edge and a monolayer where RBCs just touch without heavy overlap. Platelet estimates are approximate and lab-specific, but a common mental check is that roughly 7-20 platelets per oil immersion field often supports an adequate platelet count. If the automated platelet count is low and the smear shows clumps, the estimate should not be used as a precise substitute unless the SOP permits a specific reporting method.

Corrected and held results

Correct WBC when nRBCs are high enough to interfere, commonly when more than 10 nRBCs per 100 WBCs are present. The formula is corrected WBC = observed WBC x 100 / (100 + nRBCs per 100 WBCs) . Report nRBCs according to policy so the clinician understands the correction.

Do not release a result just because a repeat matches the first run if both runs used the same bad specimen. Repeating a clotted sample, underfilled citrate tube, or cold-agglutinin specimen without corrective action only reproduces the same problem. The MLT quality decision is to identify the source of error and choose the correct next step.

Manual differential and escalation decisions

Manual differential or pathologist review may be required for new blasts, Auer rods, marked left shift, unexplained cytopenias, critical WBC values, platelet clumps with severe thrombocytopenia, schistocyte flags, malaria or parasite suspicion, significant nRBCs, or results that fail delta checks. Each lab has its own review criteria, but the exam logic is stable: abnormal automated data must be correlated with specimen quality and smear findings before final reporting.

For hemostasis specimens, quality flags are just as important. Underfilled citrate tubes, high hematocrit without citrate adjustment, clotted specimens, heparin contamination, delayed processing, and wrong order of draw can create prolonged PT/aPTT results that mimic disease. Always solve preanalytic problems before interpreting rare disorders.